September 22, 2025
Every minute, complications during pregnancy and childbirth claim the life of a woman somewhere in the world. Many of these outcomes could be prevented through early identification and intervention of maternal health risks, yet gaps in care persist.
Maternal Anemia: A Silent Crisis
Maternal anemia, affecting up to 1 in 4 pregnant women, remains one of the most under-addressed conditions in prenatal care. It increases the risks of postpartum hemorrhage, blood transfusions, and adverse neonatal outcomes like low birth weight and preterm delivery. Addressing maternal anemia is not just a clinical challenge but also an operational and technological one, as healthcare systems often lack the tools to detect and manage risks early.
Maternal anemia, primarily caused by iron deficiency, is a global issue that impacts both mothers and babies. This condition increases the risk of postpartum complications, emergency blood transfusions, and poor neonatal outcomes. Many cases of anemia go undetected during routine prenatal visits due to outdated screening methods. By the time it’s identified, treatment options are often limited, leading to costly and urgent interventions.
The equity implications are also significant. Maternal anemia disproportionately affects underserved populations, contributing to racial disparities in maternal health outcomes. Early detection is not only a clinical priority but also a vital step towards advancing health equity.
The Case for IV Iron Infusions
Intravenous (IV) iron infusions offer a transformative approach to managing maternal anemia. Unlike oral supplements, which are often slow and poorly tolerated, IV iron delivers rapid improvements in hemoglobin levels. Studies have shown that IV iron can reduce the need for emergency transfusions, improve oxygenation for mothers and babies, and cut down on preterm births and extended hospital stays.
The financial benefits are clear, too. Treating 30% of anemic patients in a practice managing 1,000 pregnancies annually could prevent several transfusions and preterm births, saving $32,000 while generating $47,600 in IV iron revenue—a net gain of nearly $80,000. Proactive IV iron therapy turns these outcomes into strategic advantages for OB/GYN practices.
The Role of Advanced Reporting
Effective maternal care depends on data-driven decision-making. However, many healthcare systems lack integrated reporting tools, leading to fragmented data and missed opportunities for improvement. Advanced reporting platforms provide real-time insights into patient populations, screening performance, and treatment outcomes. These analytics support better care strategies while meeting quality metrics tied to healthcare reimbursement.
Comprehensive reporting is especially critical as practices strive to reduce maternal complications, improve patient satisfaction, and optimize resource allocation. Accurate, actionable data is no longer optional—it’s essential for driving excellence in maternal care.
Introducing hc1 HerCare™
hc1 HerCare revolutionizes maternal risk management through automation and advanced analytics. The platform integrates seamlessly with EHR systems, using proprietary algorithms to identify at-risk patients and prioritize care. Automated alerts and treatment recommendations are delivered directly into clinical workflows, enabling providers to act quickly and effectively.
HerCare also features a robust reporting suite, offering visibility into key metrics like anemia screening rates and patient outcomes. This empowers healthcare leaders to optimize care programs and demonstrate measurable success.
Why Proactive Risk Management Matters
Shifting from reactive to proactive care is a game-changer in maternal health. Early risk detection not only improves patient outcomes but also enhances operational efficiency and financial performance for OB/GYN practices. hc1 HerCare enables this shift by providing the tools needed to identify and address risks before they escalate.
The future of maternal care lies in predictive analytics, seamless automation, and evidence-based protocols. HerCare equips providers with the resources to transform their approach, ensuring every mother and baby receives the exceptional care they deserve.
____________________
Melissa Hollo is a Director of Program Management for hc1. Melissa partners with clients to identify opportunities for operational efficiency, standardization, and quality improvement, while also ensuring that solutions are scalable and tailored to meet unique organizational needs. By integrating advanced analytics with proven process improvement methodologies, she enables hospitals and health systems to deliver measurable results in both patient care and financial performance. Previously, Melissa held progressive leadership positions within large healthcare systems, including University Hospitals in Cleveland, where she consistently applied Lean Six Sigma methodologies to enhance efficiency, reduce costs, and build high-performing teams.
